Literature DB >> 18438706

Utility of metformin in breast cancer treatment, is neoangiogenesis a risk factor?

Vuk Stambolic, James R Woodgett, I George Fantus, Kathleen I Pritchard, Pamela J Goodwin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18438706     DOI： 10.1007/s10549-008-0015-4

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  12 in total

1.  Reversing the reduced level of endometrial GLUT4 expression in polycystic ovary syndrome: a mechanistic study of metformin action.

Authors:  Xin Li; Peng Cui; Hong-Yuan Jiang; Yan-Rong Guo; Bano Pishdari; Min Hu; Yi Feng; Håkan Billig; Ruijin Shao
Journal:  Am J Transl Res       Date:  2015-03-15       Impact factor: 4.060

Review 2.  Therapeutic Concentrations of Metformin: A Systematic Review.

Authors:  Farshad Kajbaf; Marc E De Broe; Jean-Daniel Lalau
Journal:  Clin Pharmacokinet       Date:  2016-04       Impact factor: 6.447

3.  Metformin as an energy restriction mimetic agent for breast cancer prevention.

Authors:  Zongjian Zhu; Weiqin Jiang; Matthew D Thompson; John N McGinley; Henry J Thompson
Journal:  J Carcinog       Date:  2011-07-19

4.  Normalizing glucose levels reconfigures the mammary tumor immune and metabolic microenvironment and decreases metastatic seeding.

Authors:  Heba Allah M Alsheikh; Brandon J Metge; Chae-Myeong Ha; Dominique C Hinshaw; Mateus S V Mota; Sarah C Kammerud; Tshering Lama-Sherpa; Noha Sharafeldin; Adam R Wende; Rajeev S Samant; Lalita A Shevde
Journal:  Cancer Lett       Date:  2021-05-28       Impact factor: 9.756

5.  Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway.

Authors:  Jung-Soon Mo; Zhipeng Meng; Young Chul Kim; Hyun Woo Park; Carsten Gram Hansen; Soohyun Kim; Dae-Sik Lim; Kun-Liang Guan
Journal:  Nat Cell Biol       Date:  2015-03-09       Impact factor: 28.824

6.  Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug.

Authors:  Cecilia Garofalo; Mariantonietta Capristo; Maria Cristina Manara; Caterina Mancarella; Lorena Landuzzi; Antonino Belfiore; Pier-Luigi Lollini; Piero Picci; Katia Scotlandi
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

Review 7.  Obesity and cancer, a case for insulin signaling.

Authors:  Y Poloz; V Stambolic
Journal:  Cell Death Dis       Date:  2015-12-31       Impact factor: 8.469

8.  Metformin disrupts malignant behavior of oral squamous cell carcinoma via a novel signaling involving Late SV40 factor/Aurora-A.

Authors:  Chang-Han Chen; Hsin-Ting Tsai; Hui-Ching Chuang; Li-Yen Shiu; Li-Jen Su; Tai-Jan Chiu; Sheng-Dean Luo; Fu-Min Fang; Chao-Cheng Huang; Chih-Yen Chien
Journal:  Sci Rep       Date:  2017-05-02       Impact factor: 4.379

Review 9.  Metformin against cancer stem cells through the modulation of energy metabolism: special considerations on ovarian cancer.

Authors:  Tae Hun Kim; Dong Hoon Suh; Mi-Kyung Kim; Yong Sang Song
Journal:  Biomed Res Int       Date:  2014-06-24       Impact factor: 3.411

10.  Enhanced Response of Metformin towards the Cancer Cells due to Synergism with Multi-walled Carbon Nanotubes in Photothermal Therapy.

Authors:  Sweejiang Yoo; Jin Hou; Wenhui Yi; Yingchun Li; Weiping Chen; Lingjie Meng; Jinhai Si; Xun Hou
Journal:  Sci Rep       Date:  2017-04-21       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.